UniProtKB/Swiss-Prot Q8IWL1 : Variant p.Ala91Pro
Pulmonary surfactant-associated protein A2
Gene: SFTPA2
Feedback ?
Variant information
Variant position:
91
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LB/B
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Alanine (A) to Proline (P) at position 91 (A91P, p.Ala91Pro).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from small size and hydrophobic (A) to medium size and hydrophobic (P)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Polymorphism:
At least 6 alleles of SFTPA2 are known: 1A, 1A(0), 1A(1), 1A(2), 1A(3) and 1A(4). The sequence shown is that of allele 1A(2).
Additional information on the polymorphism described.
Variant description:
In allele 1A.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
91
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
248
The length of the canonical sequence.
Location on the sequence:
GNNGLPGAPGVPGERGEKGE
A GERGPPGLPAHLDEELQATL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
21 – 248
Pulmonary surfactant-associated protein A2
Domain
28 – 100
Collagen-like
Region
33 – 101
Disordered
Literature citations
Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein.
Floros J.; Steinbrink R.; Jacobs K.; Phelps D.; Kriz R.; Recny M.; Sultzman L.; Jones S.; Taeusch H.W.; Frank H.A.; Fritsch E.F.;
J. Biol. Chem. 261:9029-9033(1986)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; ACETYLATION; VARIANTS ASN-9 AND PRO-91;
Submission
SeattleSNPs variation discovery resource;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ASN-9; LEU-50; PRO-91 AND LYS-223;
Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.
Wang Y.; Kuan P.J.; Xing C.; Cronkhite J.T.; Torres F.; Rosenblatt R.L.; DiMaio J.M.; Kinch L.N.; Grishin N.V.; Garcia C.K.;
Am. J. Hum. Genet. 84:52-59(2009)
Cited for: VARIANTS ASN-9; TRP-12; LEU-50; PRO-91 AND LYS-223; VARIANTS ILD2 SER-198 AND VAL-231;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.